Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1996-12-27
2000-03-07
Gupta, Yogendra N.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514618, 514619, 514627, 514602, 514603, 514605, 514518, 558 44, 558 55, 558 56, 564 80, 564 95, 564161, 564162, 564164, 564165, A61K 31185, A61K 3118, C07C30924, C07C25708
Patent
active
060341270
ABSTRACT:
Amidino and benzamidino compounds, including compounds of the formula: ##STR1## wherein R.sup.1 -R.sup.4, R.sup.6 -R.sup.9, Y, Z, n and m are set forth in the specification, as well as hydrates, solvates or pharmaceutically acceptable salts thereof, that inhibit a number of proteolytic enzymes are described. Also described are methods for preparing the compounds of Formula I.
REFERENCES:
patent: 3577432 (1971-05-01), Helsley
patent: 4433152 (1984-02-01), Muramatsu et al.
patent: 5260307 (1993-11-01), Ackermann et al.
patent: 5466811 (1995-11-01), Alexander
Benkert, B. et al., "Relations between structure and the noradrenaline depleting effects for guanidine and amidine derivatives," Chem. Abstr. 83:188217s (1975).
Brzozowski, Z., "Derivatives of 2-mercaptobenzenesulfonamide. I. Synthesis of some S-and N-substituted derivatives of 4-chloro-2-mercapto-5-methylbenzenesulfonamide," Acta Pol. Pharm. 44(6):486-490 (1987).
Jameson, G. W. and D. T. Elmore, "Affinity Chromatography of Bovine Trysin. A Rapid Separation of Bovine .alpha.-and .beta.-Trypsin," Biochem. J. 41:555-565 (1974).
Partial European Search Report, EP 96 94 4847 (1999).
Coats, Eugene A., "Comparative Inhibition of Thrombin, Plasmin, Trypsin, and Complement by Benzamidines Using Substituent Constants and Regression Analysis," Journal of Medical Chemistry, vol. 16, No. 10, 1102-1106 (1973).
Baker, B.R. et al., "Irreversible Enzyme Inhibitors, CLII..sup.1.2 Proteolytic Enzyme. X..sup.3 Inhibition of Guinea Pig Complement by Substituted Benzamidines, " Journal of Medical Chemstry 12(3), 408-414 (1969).
Chemical Abstract, Columbus, Ohio, vol. 27-08 (1984).
Geratz, J.D. et al., "New Aromatic Diamidines with Central .alpha.-Oxyalkane or .alpha.,.omega.-Dioxyalkane Chains. Structure-Activity Relationship for the Inhibition of Trypsin, Pancreatic Kallikrein, and thromblin and for the Inhibition of the Overall Coagulation Process, " Journal of Medical Chemistry, vol. 18., No. 5, 477-481 (1975).
Lespagnol, A. et al., "Investigation of the series of diuretic sulfonamide derivatives," Chem. Abstr. 63:525 (1965).
Miyamoto, S. and M. Kojima, "N.sup.4 -(.omega.-Guanidinoalkanoyl)sulfanilamides," Chem. Abstr. 85:159726t (1976), English abstract of JP 51-75042 (Doc. AM1).
Nippon Chemifar Co., Ltd., "Piperidine derivatives," Chem. Abstr. 101:38355m (1984), English abstract of JP 58-194861 (Doc. AN1).
Protiva, M. et al., "Hypotensive 1-benzyl-4-guanylpiperazines," Chem. Abstr. 82:140187j (1975).
Ryznerski, Z. et al., "Synthesis and Pharmacological Properties of Phenoxyethylpiperazine Derivatives, " Pol. J. Pharmacol. Pharm. 41:191-199 (1989).
Saulnier, M. G. et al., "An Efficient Method for the Synthesis of Guanidino Prodrugs," Bioorgan. Med. Chem. Letts. 4(16) :1985-1990 (1994).
Somorin, O. and L. Ameghashitsi, "Synthesis of New Arginine Derivatives as Substrates of Trypsin," Bull. Chem. Soc. Jpn. 59 :1593-1595 (1986).
Takahashi, T. and H. Sugimoto, "Quinazoline compounds," Chem. Abstr. 85 :46769 (1976), English abstract of JP 50-140474 (Doc. AL1).
Illig Carl R.
Lu Tianbao
Soll Richard M.
Tomczuk Bruce E.
3-Dimensional Pharmaceuticals Inc.
Gupta Yogendra N.
LandOfFree
Amidino protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amidino protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amidino protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-363691